Morgan Adam
- SEC CIK
- 0001964335
No open-market purchases or sales filed in the past year.
Current role at each company
- HRTX Heron Therapeutics, Inc.Directoras of Feb 3, 2026
- ALIM Alimera Sciences IncDirector, 10% Owneras of Sep 16, 2024
- JSPR Jasper Therapeutics, Inc.10% Owneras of Feb 9, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Morgan Adam as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
HRTX Heron Therapeutics, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 (view filing) | Aug 8 | 4 days | Morgan AdamDirector | PPurchase | +1.77M | $1.50 | +$2.65M | +25.3%8.75M after | |
| Aug 12, 2025 (view filing) | Aug 8 | 4 days | Morgan AdamDirector | PPurchase | +700.1K | $1.50 | +$1.05M | –70.0K after | Derivative |
| Jul 25, 2023 (view filing) | Jul 21 | 4 days | Morgan AdamDirector | PPurchaseCommon Stock, par value $0.01 per share | +2.49M | $1.37 | +$3.41M | +55.3%6.99M after | |
| Jul 25, 2023 (view filing) | Jul 21 | 4 days | Morgan AdamDirector | PPurchaseCommon Stock, par value $0.01 per share | +1.16M | $1.37 | +$1.59M | –1.16M after | Derivative |
JSPR Jasper Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 9, 2024 (view filing)8:40 PM ET | Feb 8 | 1 day | Venkataraman Balaji and 8 others10% Owner | PPurchaseCommon Stock, par value $0.0001 per share | +350.0K | $12.95 | +$4.53M | +41.7%1.19M after |
ALIM Alimera Sciences Inc
Director, 10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 19, 2023 (view filing)5:17 PM ET | May 17 | 2 days | Morgan AdamDirector, 10% Owner | PPurchase | +1.40M | $1.70 | +$2.38M | +543.9%1.66M after | |
| May 19, 2023 (view filing)5:17 PM ET | May 17 | 2 days | Morgan AdamDirector, 10% Owner | PPurchaseSeries B Convertible Preferred Stock | +15.1K | – | – | –7.00K after | Derivative2 lots |